Excessive polypharmacy and survival in polypathological patients.

Jesús Díez ManglanoMercedes Giménez-LópezVanesa Garcés-HornaMaría Sevil-PurasElena Castellar-OtínPaloma González-GarcíaIsabel Fiteni-MeraTeresa Morlanes-Navarronull null

Published in: European journal of clinical pharmacology (2015)

A greater use of drugs may not be harmful but is also not associated with a higher probability of survival in polypathological patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
body mass index
adverse drug
electronic health record